CDXG(SH:600353)2022-04-25 16:00Financial Performance - The company's operating revenue for Q1 2022 was ¥229,473,052.36, representing a 50.34% increase compared to the same period last year[6] - The net profit attributable to shareholders of the listed company was ¥10,653,528.18, reflecting a 5.67% increase year-on-year[6] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥10,296,475.51, which is a 23.35% increase compared to the previous year[6] - The basic earnings per share for the period was ¥0.0196, an increase of 4.81% year-on-year[9] - Net profit rose to ¥15,903,465.95, up from ¥11,238,286.15, indicating a growth of approximately 42.4%[29] - Total profit reached ¥18,523,490.75, compared to ¥13,087,895.34, marking an increase of about 41.5%[29] - Operating profit improved to ¥18,273,490.75 from ¥13,099,503.00, reflecting a growth of approximately 39.5%[29] - Basic and diluted earnings per share increased to ¥0.0196 from ¥0.0187, showing an improvement of about 4.8%[31] Cash Flow and Assets - The net cash flow from operating activities was -¥57,551,277.55, indicating a significant cash outflow[6] - Cash flow from operating activities showed a net outflow of ¥57,551,277.55, worsening from a net outflow of ¥19,347,095.11[34] - Cash and cash equivalents at the end of the period decreased to ¥130,185,863.84 from ¥138,570,204.64[36] - The total assets at the end of the reporting period were ¥1,879,898,432.27, an increase of 1.74% from the end of the previous year[9] - Total assets amounted to CNY 1,879,898,432.27 in Q1 2022, compared to CNY 1,847,812,678.82 in Q1 2021, showing a growth of approximately 1.7%[25] Liabilities and Equity - The equity attributable to shareholders of the listed company was ¥1,211,427,569.30, up by 1.07% from the end of the previous year[9] - The company's equity attributable to shareholders increased to CNY 1,211,427,569.30 in Q1 2022 from CNY 1,198,575,079.34 in Q1 2021, reflecting a growth of approximately 1.1%[25] - Total liabilities decreased to CNY 478,930,603.23 in Q1 2022 from CNY 485,531,220.95 in Q1 2021, a decline of about 1.2%[23] - Short-term borrowings increased significantly to CNY 67,776,310.37 in Q1 2022 from CNY 32,569,252.77 in Q1 2021, indicating a rise of about 107.5%[23] Operational Insights - The company attributed the increase in operating revenue to higher sales volume of main products and the consolidation of subsidiaries into the financial statements[9] - The company reported a net profit margin improvement due to increased operational efficiency, although specific figures were not disclosed in the provided data[25] - The company did not report any significant new product developments or market expansion strategies during this quarter[16] - The company plans to expand its market presence and invest in new product development to drive future growth[25] Research and Development - R&D expenses increased to ¥11,376,496.33 from ¥5,231,053.69, representing a significant rise[29] Other Financial Metrics - Non-recurring gains and losses for the period totaled ¥357,052.67, after accounting for tax effects and minority interests[9] - The company reported a significant increase in other income, amounting to ¥250,000.00 compared to a loss of ¥11,607.66 in the previous period[29] - The company experienced a credit impairment loss of ¥3,629,390.76, compared to a loss of ¥333,371.43 previously, indicating a deterioration in credit quality[29] - The company raised ¥5,200,000.00 from minority shareholders as part of its financing activities[34]